Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



IBM Envisions a Small, Profitable Future

In a paper that appeared in Nature Nanotechnology today, IBM (NYSE: IBM  ) researchers have reported that they have used magnetic resonance imaging techniques to visualize objects as small as 90 nanometers. From a short-term, commercial perspective, this news is nothing particularly exciting. But if you're a long-term investor, it should pique your interest, because this advance represents a major milestone in being able to take 3-D images of all of the atoms in a single molecule.

For instance, such a detailed level of imaging could provide scientists and researchers a greatly enhanced understanding of how proteins function within the human body. That knowledge, in turn, could lead to the creation of new mechanisms for drug treatments.

And it doesn't stop there. Computer engineers could use this technology to pinpoint the precise location of specific atoms within a tiny nanoelectronic structure, to create better-performing devices. Similarly, material scientists could employ the tool to ensure that high-performance materials -- such as the type that will be used in the construction of next-generation aircraft -- don't experience any breakdowns at the atomic level.

It is too early to determine whether IBM envisions selling this equipment to individual companies or whether it intends to sell "access" to the equipment -- and consulting expertise -- to users. But it is clear that a number of clients in the pharmaceutical, aerospace, and chemical industries with whom IBM already has pre-existing relationships -- including Pfizer (NYSE: PFE  ) , Ford (NYSE: F  ) , and Dow Chemical (NYSE: DOW  ) -- will be very interested in getting their hands on either the equipment or the capability, and that'll be good news for investors.

Interested in reading more about IBM? Check out these articles:

Dow Chemical is anIncome Investor pick. Pfizer is anInside Value recommendation. Try out either Foolish newsletter service free for 30 days.

Fool contributor Jack Uldrich owns stock IBM. The Fool has a strict disclosure policy.

Read/Post Comments (0) | Recommend This Article (11)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 526263, ~/Articles/ArticleHandler.aspx, 10/25/2016 4:56:12 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:02 PM
IBM $150.57 Up +0.94 +0.63%
IBM CAPS Rating: ****
DOW $54.24 Up +0.14 +0.26%
The Dow Chemical C… CAPS Rating: *****
F $12.19 Up +0.17 +1.41%
Ford CAPS Rating: ****
PFE $32.13 Down -0.05 -0.16%
Pfizer CAPS Rating: ****